Counting undiagnosed hepatitis B, C and D in Austria
Part of Digestive system, Infections clinical trials.
This study is looking for people in south-east Austria who have hepatitis B (HBV) or hepatitis C (HCV) that hasn't been fully treated or documented. It aims to find how many people also have hepatitis D (HDV) and are not yet aware of it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have at least one of these hepatitis viruses: hepatitis B (HBV) or hepatitis C (HCV).
- If you have HCV, you must still have the virus active in your blood (positive HCV RNA) and have not been cured yet.
- If you have HBV, you must have had the virus in your blood at some point (positive HBV DNA or RNA), and you either have not been tested for hepatitis D (HDV) or have tested positive for it.
- You must have a valid social insurance number and your contact information must be available in health records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both HIV and hepatitis B over time to better understand how the infection responds after starting treatment. Your information (and sometimes stored blood samples) helps researchers track changes from the start of therapy to about 2 years later.
This study looks at women with chronic hepatitis B or C to understand their current health status. It may help researchers find better ways to support patients like you.
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study follows adults with long-term (chronic) hepatitis B to better understand the condition over time. If you have chronic hepatitis B, it may help researchers improve care for people with the infection.
This research study follows people with hepatitis B (a liver infection) in Zambia to understand how their bodies respond to treatment and what happens to the virus over time. It includes people with hepatitis B alone, those also living with HIV, and those whose hepatitis B has cleared.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.